Chronic lymphocytic leukemia with progressive anemia secondary to development of composite lymphoma
Deterioration of hematologic parameters in lymphoma patients is often attributed to disease progression, comorbidities, or treatment effects. Second primary malignancies occur at increased frequency in CLL and must also be considered. AbstractDeterioration of hematologic parameters in lymphoma patients is often attributed to disease progression, comorbidities, or treatment effects. Second primary malignancies occur at increased frequency in CLL and must also be considered.
Source: Clinical Case Reports - Category: General Medicine Authors: Eric McGinnis,
James T. England,
Jeffrey W. Craig,
Habib Moshref Razavi Tags: CLINICAL IMAGE Source Type: research
More News: Anemia | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | General Medicine | Hematology | Leukemia | Lymphoma